Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a DNA carrier in vitro and in vivo

Journal of Drug Targeting

Volumn 20, Issue 3, 2012, Pages 272-280

  Anno, Takayuki ^a   Higashi, Taishi ^a   Motoyama, Keiichi ^a   Hirayama, Fumitoshi ^b   Uekama, Kaneto ^b   Arima, Hidetoshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b SOJO UNIVERSITY   (Japan)

Author keywords

Conjugate; Glucuronylglucosyl cyclodextrin; Nonviral vector; Polyamideamine (PAMAM) dendrimer

Indexed keywords

BETA CYCLODEXTRIN; DENDRIMER; DEOXYRIBONUCLEASE I; FLUORESCENT DYE; GLUCURONYLGLUCOSYL BETA CYCLODEXTRIN; PLASMID DNA; POLYAMIDOAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD CHEMISTRY; CATALYSIS; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONJUGATION; ENZYME DEGRADATION; FEMALE; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SUBSTITUTION REACTION; ZETA POTENTIAL;

ADENOCARCINOMA; ANIMALS; BETA-CYCLODEXTRINS; BIOLOGICAL TRANSPORT; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL NUCLEUS; DENDRIMERS; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; KIDNEY; MACROPHAGES; MICE; MICE, INBRED BALB C; NANOPARTICLES; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

EID: 84857790680     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2011.645163     Document Type: Article

References (37)

1. Anno T, Motoyama K, Higashi T, Hirayama F, Uekama K, Arima H. (2011). Preparation and evaluation of polyamidoamine dendrimer (G2)/branched-β- cyclodextrin conjugate as a novel gene transfer carrier. J Incl Phenom Macrocycl Chem, 70, 339-344
2. Arima H, Motoyama K. (2009). Recent findings concerning PAMAM dendrimer conjugates with cyclodextrins as carriers of DNA and RNA. Sensors, 9, 6346-6361.
3. Arima H, Yamashita S, Mori Y, Hayashi Y, Motoyama K, Hattori K, Takeuchi T, Jono H, Ando Y, Hirayama F, Uekama K. (2010). In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/ a-cyclodextrin conjugates (G2) into hepatocytes. J Control Release, 146, 106-117.
4. Avall-Lundqvist E, Economidou-Karaoglou A, Sjövall K, Lans M, Taper HS, Roberfroid M, Eneroth P. (1989). Serum alkaline DNase activity in normal or nonhospitalised individuals. Clin Chim Acta, 185, 35-43.
5. Banerjee P, Weissleder R, Bogdanov A Jr.(2006). Linear polyethyleneimine grafted to a hyperbranched poly(ethylene glycol)-like core: a copolymer for gene delivery. Bioconjug Chem, 17, 125-131.
6. Bellocq NC, Pun SH, Jensen GS, Davis ME. (2003). Transferrincontaining, cyclodextrin polymer-based particles for tumortargeted gene delivery. Bioconjug Chem, 14, 1122-1132.
7. Bender M, Komiyama M. (1978). Cyclodextrin chemistry, Berlin: Springer-Velag.
8. Bielinska A, Kukowska-Latallo JF, Johnson J, Tomalia DA, Baker JR Jr. (1996). Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res, 24, 2176-2182.
9. Croyle MA, Roessler BJ, Hsu CP, Sun R, Amidon GL. (1998). β cyclodextrins enhance adenoviral-mediated gene delivery to the intestine. Pharm Res, 15, 1348-1355.
10. Feinberg H, Park-Snyder S, Kolatkar AR, Heise CT, Taylor ME, Weis WI. (2000). Structure of a C-type carbohydrate recognition domain from the macrophage mannose receptor. J Biol Chem, 275, 21539-21548.
11. Felgner PL, Barenholz Y, Behr JP, Cheng SH, Cullis P, Huang L, Jessee JA, Seymour L, Szoka F, Thierry AR, Wagner E, Wu G. (1997). Nomenclature for synthetic gene delivery systems. Hum Gene Ther, 8, 511-512.
12. Freeman DJ, Niven RW. (1996). The influence of sodium glycocholate and other additives on the in vivo transfection of plasmid DNA in the lungs. Pharm Res, 13, 202-209.
13. Gabrielson NP, Pack DW. (2006). Acetylation of polyethylenimine enhances gene delivery via weakened polymer/DNA interactions. Biomacromolecules, 7, 2427-2435.
14. Huang H, Tang G, Wang Q, Li D, Shen F, Zhou J, Yu H. (2006). Two novel non-viral gene delivery vectors: low molecular weight polyethylenimine cross-linked by (2-hydroxypropyl)-β- cyclodextrin or (2-hydroxypropyl)-?- cyclodextrin. Chem Commun (Camb), 2382-2384.
15. Ilangumaran S, Hoessli DC. (1998). Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem J, 335 (Pt 2), 433-440.
16. Irie T, Uekama K. (1997). Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci, 86, 147-162.
17. Irie T, Uekama K. (1999). Cyclodextrins in peptide and protein delivery. Adv Drug Deliv Rev, 36, 101-123.
18. Isaka Y. (2006). Gene therapy targeting kidney diseases: routes and vehicles. Clin Exp Nephrol, 10, 229-235.
19. Kihara F, Arima H, Tsutsumi T, Hirayama F, Uekama K. (2002). Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with a-cyclodextrin. Bioconjug Chem, 13, 1211-1219.
20. Kihara F, Arima H, Tsutsumi T, Hirayama F, Uekama K. (2003). In vitro and in vivo gene transfer by an optimized a-cyclodextrin conjugate with polyamidoamine dendrimer. Bioconjug Chem, 14, 342-350.
21. Kukowska-Latallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker JR Jr. (1996). Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci USA, 93, 4897-4902.
22. Ledley FD. (1995). Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther, 6, 1129-1144.
23. Luo D, Saltzman WM. (2000). Synthetic DNA delivery systems. Nat Biotechnol, 18, 33-37.
24. Ma H, Diamond SL. (2001). Nonviral gene therapy and its delivery systems. Curr Pharm Biotechnol, 2, 1-17.
25. Marttin E, Verhoef JC, Merkus FW. (1998). Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs. J Drug Target, 6, 17-36.
26. Monsigny M, Rondanino C, Duverger E, Fajac I, Roche AC. (2004). Glyco-dependent nuclear import of glycoproteins, glycoplexes and glycosylated plasmids. Biochim Biophys Acta, 1673, 94-103.
27. Park MR, Han KO, Han IK, Cho MH, Nah JW, Choi YJ, Cho CS. (2005). Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers. J Control Release, 105, 367-380.
28. Qin L, Pahud DR, Ding Y, Bielinska AU, Kukowska-Latallo JF, Baker JR Jr, Bromberg JS. (1998). Efficient transfer of genes into murine cardiac grafts by Starburst polyamidoamine dendrimers. Hum Gene Ther, 9, 553-560.
29. Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B, Sandvig K. (1999). Extraction of cholesterol with methyl-β-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell, 10, 961-974.
30. Rolland AP. (1998). From genes to gene medicines: recent advances in nonviral gene delivery. Crit Rev Ther Drug Carrier Syst, 15, 143-198.
31. Saenger W. (1980). Cyclodextrin inclusion compounds in research and industry. Angew Chem Int Ed Engl, 19, 344-362.
32. Sternberg PW, Schmid SL. (1999). Caveolin, cholesterol and Ras signalling. Nat Cell Biol, 1, E35-E37.
33. Subramanian A, Ranganathan P, Diamond SL. (1999). Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells. Nat Biotechnol, 17, 873-877
34. Tomalia DA, Naylor AM, Goddard WA. (1990). Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl, 29, 138-175.
35. Uekama K, Hirayama F, Irie T. (1998). Cyclodextrin Drug Carrier Systems. Chem Rev, 98, 2045-2076.
36. Wada K, Arima H, Tsutsumi T, Chihara Y, Hattori K, Hirayama F, Uekama K. (2005a). Improvement of gene delivery mediated by mannosylated dendrimer/a-cyclodextrin conjugates. J Control Release, 104, 397-413
37. Zhao Q, Temsamani J, Agrawal S. (1995). Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery. Antisense Res Dev, 5, 185-192.